Zobrazeno 1 - 10
of 500
pro vyhledávání: '"Valenti, A"'
Autor:
M. Berteotti, A. M. Gori, B. Giusti, A. Fortini, G. Grossi, N. Ciardetti, A. Migliorini, E. Lotti, R. Valenti, C. Di Mario, N. Marchionni, R. Marcucci
Publikováno v:
Journal of Thrombosis and Thrombolysis. 55:667-679
High platelet reactivity (HPR) on clopidogrel is an established thrombotic risk factor after percutaneous coronary intervention (PCI). The introduction of more potent antiplatelet drugs has partially surpassed this issue. However, in the setting of c
Autor:
Daniela N. Vasquez, Roberto Giannoni, Adriana Salvatierra, Karina Cisneros, Diego Lafosse, María F. Escobar, Martín Montenegro, Paula Juárez, Lucía Visani, Verónica Mandich, Erika Barrozo, Mariana Kirschbaum, Andrea V. Das Neves, María F. Valenti, María C. Canseco, Ignacio Romero, Pedro Macharé, Ana K. Marquez, Eva Rodriguez, Cristina Palacio, Laura Rapela, José M. Amillategui Scenna, Rosshanna Nuñez, Sebastián Torres, Miguel A. González, Lorena Franconieri, Daniela Nasner, Patricia Okurzaty, Gustavo A. Plotnikow, Alfredo D. Intile
Publikováno v:
Chest. 163:554-566
Autor:
Maurizio Forte, Daniele Rodolico, Pietro Ameri, Daniele Catalucci, Cristina Chimenti, Lia Crotti, Leonardo Schirone, Annachiara Pingitore, Daniele Torella, Giuliano Iacovone, Valentina Valenti, Gabriele G. Schiattarella, Cinzia Perrino, Sebastiano Sciarretta
Publikováno v:
Journal of Cardiovascular Medicine. 24:e3-e14
Autor:
M Vitolo, J F Imberti, V Ziveri, N Bonini, F Muto, D A Mei, G Gozzi, C Busi, M Mantovani, B Cherubini, M Menozzi, P Cataldo, A C Valenti, D Sgreccia, G Boriani
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background The COVID-19 pandemic has highlighted the role of telemedicine in reducing face-to-face visits. Telemedicine requires either the use of digital support methods and a minimum technolog
Publikováno v:
Coronary Artery Disease.
Autor:
Gennaro Sardella, Giulio Stefanini, Pier Pasquale Leone, Giacomo Boccuzzi, Natalia Tovar Fovero, Nicolas Van Mieghem, Giuseppe Giacchi, Javier Escaned, Massimo Fineschi, Luca Testa, Renato Valenti, Carlo Di Mario, Carlo Briguori, Bernardo Cortese, Flavio Ribichini, Jacopo Andrea Oreglia, Antonio Colombo, Giuseppe Sangiorgi, Emanuele Barbato, Jeroen Sonck, Fabrizio Ugo, Carlo Trani, Fausto Castriota, Anita Paggi, Italo Porto, Fabrizio Tomai, Massimo Mancone
Publikováno v:
American Journal of Cardiology, 198. Elsevier Inc.
Debulking lesions with severe coronary artery calcification (CAC) is highly recommended to obtain good procedural and long-term success. Utilization and performance of coronary intravascular lithotripsy (IVL) after rotational atherectomy (RA) has not
Autor:
Alessandro Mantovani, Chiara Zusi, Alessandro Csermely, Antonio Taverna, Davide Cappelli, Micol Pagani, Luca Valenti, Claudio Maffeis, Giovanni Targher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60a1e75d7bbc4d231938976061b6d085
https://hdl.handle.net/11562/1094087
https://hdl.handle.net/11562/1094087
Autor:
Giacomo Virgili, Gherardo Busi, Carlo Fumagalli, Manlio Acquafresca, Mario Moroni, Angela Migliorini, Francesco Meucci, Renato Valenti, Carlo Di Mario, Niccolò Marchionni, Nazario Carrabba
Publikováno v:
European Heart Journal Supplements. 24
Background Coronary computer tomography angiography (CTA) is currently considered a reliable method to rule out obstructive coronary artery disease (O-CAD) before valvular heart surgery in patients with low-intermediate pretest probability. However,
Autor:
Niccolo Bonini, Alessandro Albini, Andrea Venturelli, Anna Maisano, Jozef Luli, Marco Vitolo, Jacopo Francesco Imberti, Anna Chiara Valenti, Ilaria Righelli, Paolo Cataldo, Federico Muto, Alberto Tosetti, Giuseppe Boriani
Publikováno v:
European Heart Journal Supplements. 24
Background and aim of the study There is a rising interest in real-world data about Sacubitril/Valsartan (Sa/Va) treatment, especially for the renal outcomes in patients treated with low (24/26 mg bid), mid (49/51 mg bid) and high (97/103 mg bid) dos
Autor:
Anna Maisano, Annachiara Valenti, Albini Alessandro, Benedetta Cherubini, Marta Mantovani, Giulio Leo, Paola Trapanese, Francesca Rampini, Filippo Federico Bertuglia, Melania Minnocci, Giuseppe Boriani
Publikováno v:
European Heart Journal Supplements. 24
Background and aim of the study There is a rising interest in cardio-oncology as an holistic approach to oncological patients with established cardiovascular comorbidities or at increased cardiovascular risk. Symptoms of potential cardiovascular sign